Researchers

Veneno is home to many experienced researchers from multiple research disciplinaries

Veneno brings together researchers with extensive experience in the fields of peptide science, drug discovery, and biotechnology.

Building on the fundamental research cultivated at the National Institute of Advanced Industrial Science and Technology (AIST), we are advancing research and development with a view to commercializing our findings as pharmaceuticals and biomaterials.

Each researcher leverages their expertise to explore the potential of DRP (Disulfide-Rich Peptide) from multiple angles.

Veneno’s strength lies in its research framework, which maintains a consistent focus from basic research through to application and commercialization.

Research scene 1 Research scene 2 Research scene 3
Pickup

Board Member

Board Members

Takatoshi Kuno Takatoshi Kuno Hover

President and CEO

Takatoshi Kuno

A business leader who has built a career spanning both industrial policy and business development. After promoting industry-academia collaboration and the creation of new industries at the Ibaraki Prefectural Government, I led innovation in the medical robotics field at CYBERDYNE. At Takeda Pharmaceutical, I participated in the launch of the Shonan Health Innovation Park and spearheaded cross-sectoral co-creation involving industry, academia, and government. At Novartis Pharma, I was responsible for external collaboration and policy liaison regarding the commercialization of new drugs, driving ecosystem development and partnership building. Furthermore, at CMIC Holdings, I am involved in new business ventures in the next-generation healthcare sector. Leveraging the implementation skills honed in the intersection of the public, private, and innovation sectors, I aim to accelerate value creation with diverse stakeholders both domestically and internationally.
Tadashi Kimura Tadashi Kimura Hover

Director & Chief Technology Officer

Tadashi Kimura

Graduated from the Department of Biology, Faculty of Science, Tohoku University. After earning a master’s degree from Sophia University Graduate School for research on the neural mechanisms underlying birdsong, I joined Mitsubishi Chemical Corporation. While engaged in general pharmacology research at the Pharmaceutical Research Institute, I discovered side effects in several drugs and halted their progression to clinical trials. Subsequently, I transferred into the doctoral program at the University of Tsukuba and earned my Ph.D. for my molecular biological research on voltage-gated calcium channels in squid at the National Research Institute of Electronics and Information Technology (NRIET). I joined the National Institute of Biotechnology (NIBT) under the Agency for Industrial Science and Technology (AIST), where I continually pondered the differences between research institutes under the Ministry of Economy, Trade and Industry (METI) and those under the Ministry of Education, Culture, Sports, Science and Technology (MEXT) or the Ministry of Health, Labour and Welfare (MHLW). Using internal competitive grants, NEDO industrial technology grants, and JST START funding, I conducted research and development on the core technologies of our company, filed patent applications, and published papers. After undergoing incubation at Blockbuster Tokyo and the University of Tsukuba’s EDGE-NEXT, I founded our company. My mission is to implement the research results from AIST into society and spread the value of disulfide-rich peptides worldwide.

Team Member

Our Researchers

Senior Researcher

Hiroo Tanaka

Hiroo Tanaka

I have been engaged in research in academia, where I have cultivated experience and knowledge in basic research. Going forward, I intend to leverage these strengths and actively pursue the practical application of DRP.

Senior Researcher

Huong Minh NGUYEN

Huong Minh NGUYEN

I am a researcher with over 10 years of experience in molecular microbiology and genetic engineering. My life philosophy is “To connect with people, you don’t need to be interesting, just interested.” Through my role at Veneno, I aim to collaborate with partners around the world to leverage disulfide-rich peptides and address health challenges affecting humans, animals, and the environment.

Senior Researcher

Takumi Okamoto

Takumi Okamoto

After earning my Ph.D., I served as a JSPS postdoctoral researcher at Shizuoka Prefectural University before taking on my current position. In my previous roles, I worked on expanding the potential of plants from the perspectives of plant genetics and secondary metabolism. Believing in the hidden potential of plants, I am committed to advancing the agricultural sector in Japan and around the world!!

Senior Researcher

Toshiaki Okada

Toshiaki Okada

I studied biology at Okayama University and earned a Ph.D. in Science. Since then, I have gained diverse experience at various research institutes and universities, including abroad. Before joining Veneno, I worked as a Specially Appointed Associate Professor at the National Institute for Physiological Sciences. While I was a university student, I was frequently stung by sea nettles, which caused me a great deal of pain and itching; however, it has been my secret dream to one day analyze their venom.

Senior Researcher

LU ZHIBO

LU ZHIBO

I graduated from Nanjing Medical University and conducted research on the electrophysiology of arrhythmias at Nagoya University and the University of Rochester. I am confident in my ability to apply my knowledge of medicine, research, and healthcare, as well as my experience in business—including import/export, exhibitions, presentations, and training—to take on new challenges in different fields.

Research Scientist

Moeka Nakamura

Moeka Nakamura

I obtained my Master’s Degree at the Graduate School of Medical, Dental and Pharmaceutical Sciences, Nagasaki University. Before joining our company, I worked as a Researcher at the Research Department, Research and Development Division of Miyarisan Pharmaceutical Co., Ltd.
I aim to learn across disciplines and work toward the societal implementation of DRP!

Senior Researcher

Tomohiro Yamaguchi

Tomohiro Yamaguchi

I am fascinated by the mechanisms by which membrane proteins move and function. At Veneno, I was particularly drawn to the functional beauty of DRP, which maintains its activity despite its ultra-compact structure. I want to vividly imagine how DRP interacts with its targets and create new DRP variants that will be useful in society.

Research Scientist

Anna Iwaki

Anna Iwaki

After completing my master’s degree, I worked in academic research and diagnostic drug development in life sciences before assuming my current position. During my graduate studies, I conducted research on pain in the field of pharmacology, and I am currently engaged in research focused on the creation of target-specific peptides.

Senior Researcher

Dan Sato

Dan Sato

My areas of expertise include biochemistry, enzymology, metabolomics, and structural analysis.
The properties of DRP—which differ from both proteins and conventional peptides—are truly fascinating. It makes perfect sense that organisms have utilized them as toxins. DRP can accomplish things that proteins, peptides, nucleic acids, and small molecules cannot.

Senior Researcher

Takashi Nishiyama

Takashi Nishiyama

I graduated from Tokyo Institute of Technology (now Tokyo University of Science). After working at Kyoto University, the University of Tokyo, and other institutions, I assumed my current position. My strengths lie in protein engineering, which integrates diverse technical expertises, medical insights, and chemical approaches. Working to connect and align academic passion with industrial needs, I am committed to advancing the societal implementation of DRP and creating new value.

Senior Researcher

Kazuhiro Yamada

Kazuhiro Yamada

After completing my graduate studies, I worked at the Institute of Biomolecular Engineering, ETH Zurich, the Max Planck Institute for Medical Research, and Osaka University Ventures before assuming my current position. My primary research fields are structural biology and biochemistry. While marveling at the young talents who wield AI with such ease, I am also honing my own skills in this field. Let’s work hard together!

Research Scientist

Moe Okamoto

Moe Okamoto

I have gained experience working as a research assistant at various universities and companies. Our company brings together researchers with diverse areas of expertise, and I believe that the strength of our team comes from the convergence of our individual insights. I aim to be a source of flexible support so that all our researchers can focus on their work with peace of mind.

Assistant Director, Research Planning Department

Shinichiro Egashira

Shinichiro Egashira

I am truly impressed by the rapid pace of AI development these days.
While I can’t help but feel envious when I think about how different my learning and experiences would have been if this technology had existed when I was younger, I also believe that it is precisely those of us who lived through the pre-AI era who can truly appreciate and learn from these advancements.
I hope that those who have come to know Veneno’s technology through our collaborative research will share this same sense of wonder.

・Professional Experience
Drug Discovery Research: Banyu Pharmaceutical (now MSD Pharmaceutical) Tsukuba Research Institute, The University of Tokyo Institute for Drug Discovery, Mochida Pharmaceutical Drug Discovery Research Institute
Pharmaceutical Development: Mochida Pharmaceutical Pharmaceutical Development Department, Development Planning and Promotion Department, Medical Affairs Department

I spent 20 years in drug discovery research and the subsequent 10 years in pharmaceutical development (clinical and post-marketing). Although both fall within the “drug discovery” field, I learned through my experiences in each setting that perspectives and ways of thinking change significantly depending on one’s role, and that there are many different entry points into drug discovery. I look forward to speaking with people from diverse backgrounds who are exploring various approaches to drug discovery while working together.